BIOMAT Database Logo BIOMAT Database Logo

Amino acids and peptides. XXXIX. Synthesis of iNoc-Gln-Val-Val-Ala-Ala-pNA and its action on thiol proteinases. 1995

Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Faculty of Pharmaceutical Sciences, Kobe-Gakuin University, Japan.

Based on the results of X-ray analysis of the complex between Suc-Gln-Val-Val-Ala-Ala-pNA, a fairly potent thiol proteinase inhibitor, and papain, iNoc-Gln-Val-Val-Ala-Ala-pNA was designed and prepared and its inhibitory activity against thiol proteinases was examined. iNoc-Gln-Val-Val-Ala-Ala-pNA inhibited cathepsin L fairly specifically, although its potency is not high.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002403 Cathepsins A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES. Cathepsin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015853 Cysteine Proteinase Inhibitors Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. Acid Cysteine Proteinase Inhibitor,Cysteine Protease Inhibitor,Cysteine Protease Inhibitors,Cysteine Proteinase Antagonist,Cysteine Proteinase Antagonists,Cysteine Proteinase Inhibitor,Cysteine Proteinase Inhibitors, Endogenous,Cysteine Proteinase Inhibitors, Exogenous,alpha-Cysteine Protease Inhibitor,Acid Cysteine Proteinase Inhibitors,alpha-Cysteine Protease Inhibitors,Antagonist, Cysteine Proteinase,Antagonists, Cysteine Proteinase,Inhibitor, Cysteine Protease,Inhibitor, Cysteine Proteinase,Inhibitor, alpha-Cysteine Protease,Inhibitors, Cysteine Protease,Inhibitors, Cysteine Proteinase,Inhibitors, alpha-Cysteine Protease,Protease Inhibitor, Cysteine,Protease Inhibitor, alpha-Cysteine,Protease Inhibitors, Cysteine,Protease Inhibitors, alpha-Cysteine,Proteinase Antagonist, Cysteine,Proteinase Antagonists, Cysteine,Proteinase Inhibitor, Cysteine,Proteinase Inhibitors, Cysteine,alpha Cysteine Protease Inhibitor,alpha Cysteine Protease Inhibitors
D016415 Sequence Alignment The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms. Sequence Homology Determination,Determination, Sequence Homology,Alignment, Sequence,Alignments, Sequence,Determinations, Sequence Homology,Sequence Alignments,Sequence Homology Determinations

Related Publications

Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Amino acids and peptides. XV. Synthesis of Gln-Val-Val-Ala-Gly and derivatives, a common sequence of thiol proteinase inhibitors and their effects on thiol proteinase.
July 1987, International journal of peptide and protein research,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Amino acids and peptides. XX. Inhibition of papain by succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide, a common sequence of endogenous thiol proteinase inhibitors.
June 1988, Chemical & pharmaceutical bulletin,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Significant effects of synthetic Gln-Val-Val-Ala-Gly and its derivatives, common sequences of thiol proteinase inhibitors, on thiol proteinase.
November 1985, Chemical & pharmaceutical bulletin,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Significant effects of Z-Gln-Val-Val-OME, common sequences of thiol proteinase inhibitors on thiol proteinases.
March 1987, Biochemical and biophysical research communications,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Amino acids and peptides. XXVIII. Preparation of poly(ethylene glycol) hybrids of Gln-Val-Val-Ala-Gly analogs and their inhibitory effect on papain.
June 1996, Biological & pharmaceutical bulletin,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Amino acids and peptides. XVII. Synthesis of a tridecapeptide corresponding to the sequence 165-177 of T-kininogen (tryptic peptide) containing Gln-Val-Val-Ala-Gly sequence and the relationship between structure and effect on thiol proteinase.
September 1987, Chemical & pharmaceutical bulletin,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Amino acids and peptides. XL. Synthesis of Ac-Tyr-Val-Ala-Asp-MCA using newly developed acetylating reagent.
August 1995, Chemical & pharmaceutical bulletin,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
[Synthesis and biological activity of some Val(Ala)-Tyr and Val-Tyr-Tyr peptides].
January 1992, Yao xue xue bao = Acta pharmaceutica Sinica,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Synthesis of bradykinyl-Val-Ala-Pro-Ala-Ser-OH and its biological propertieS.
March 1973, Chemical & pharmaceutical bulletin,
Y Okada, and Y Tsuda, and Y Mu, and K Hirano, and H Okamoto, and Y Okamoto, and H Kakegawa, and H Matsumoto, and T Sato
Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7-A resolution: noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors.
November 1992, Biochemistry,
Copied contents to your clipboard!